GLADSTONE COMMERCIAL CORP
No SEC Form 4 filings for $GOOD in the last 30 days.
New Zealand’s S&P/NZX 50 fell 0.2% to 12,970.28 as exporters and property stocks were broadly weaker ahead of Fisher & Paykel Healthcare’s annual earnings on Tuesday and Goodman New Zealand’s results. F&P shares slipped 1.3% to $33.66. Oceania Healthcare rose 2.8% after brokers lifted targets. Outside the index, Pacific Edge gained 3.7% while Eroad fell 8% after missing guidance; Ampfield seeks board control.
JPMorgan Chase & Co. has significantly increased its stake in Gladstone Commercial Corporation (NASDAQ:GOOD) by 56.8% in the third quarter, now owning 336,791 shares valued at $4.15 million. While Gladstone Commercial offers a high annualized dividend yield of 10.3%, its extremely high payout ratio of 857.14% raises concerns about its sustainability. The company recently reported mixed quarterly results, missing EPS estimates but beating revenue expectations, and currently holds a consensus "Hold" rating from analysts with an average price target of $12.75.
Zacks.com users have recently been watching Gladstone Commercial (GOOD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
